H-L-Leu-pNA is an L-leucine-derived amino acid derivative in which the amino acid is coupled to p-nitroanilide (pNA), forming a peptide-like substrate with a leucine side chain. The molecule contains a free carboxamide-type functional group associated with p-nitroanilide and an L-leucine backbone featuring the characteristic isobutyl side chain, while the stereochemistry is specified as L by the product name. H-L-Leu-pNA is used in biochemical and analytical assays as a chromogenic substrate, where the p-nitroanilide moiety provides a measurable colorimetric readout upon cleavage of the leucine-pNA linkage.
CAT No: CP25839
CAS No:4178-93-2
Synonyms/Alias:4178-93-2;L-LEUCINE-4-NITROANILIDE;(S)-2-Amino-4-methyl-N-(4-nitrophenyl)pentanamide;L-Leucine-p-nitroanilide;(2S)-2-amino-4-methyl-N-(4-nitrophenyl)pentanamide;L-Leucyl-p-nitroanilide;L-Leup-nitroanilide;AmbotzHAA1182;AC1MBYJA;H-LEU-PNA;L-Leucine-p-nitroaniline;D-Val-Leu-Lys-pan2HCl;L-Leucine-para-nitroanilide;AC1Q1O9C;CHEMBL12996;L9125_SIGMA;SCHEMBL515029;BDBM23972;AXZJHDNQDSVIDR-NSHDSACASA-N;MolPort-001-846-015;ZINC4262395;7331AH;AKOS010367898;AJ-49889;AK163538
Chemical Name:L-Leucine p-nitroanilide
H-L-Leu-pNA is a leucine-derived peptidyl substrate analog featuring the L-leucine stereocenter linked through an amide bond to p-nitroanilide (pNA), where the p-nitroanilide chromophore enables spectrophotometric readout upon enzymatic cleavage. The structure combines an α-amino acid framework with a free carboxamide functionality (as part of the pNA leaving group motif) and a hydrophobic isobutyl side chain characteristic of L-leucine, giving predictable recognition by protease active sites that prefer leucine-like residues. The para-nitroanilide moiety is electronically activated and undergoes strong color change upon release, making the compound behave as a reactive analytical handle rather than a stable peptide building block. As a chiral amino acid derivative, H-L-Leu-pNA is designed to probe stereospecific substrate recognition and to serve as a controlled intermediate for developing related amino acid-pNA conjugates used in assay and method development.
1. Protease Activity Assays
H-L-Leu-pNA is used in biochemical screening and enzymology workflows to quantify protease activity through cleavage-linked liberation of p-nitroaniline, enabling kinetic monitoring by UV-Vis detection. The L-leucine side chain provides a defined hydrophobic residue environment that can match protease substrate pockets requiring leucine-like specificity, while the pNA leaving group supplies the measurable chromophore. The amide linkage positions the substrate scissile bond in a geometry suitable for enzyme recognition, allowing assay conditions to be tuned for substrate specificity studies. Downstream use includes generating structure-activity relationship datasets across leucine and related side-chain variants to map protease preference patterns in research and industrial enzyme characterization.
2. Peptidase Specificity Profiling
H-L-Leu-pNA functions as a chiral substrate probe for mapping peptidase selectivity across enzyme families that recognize L-amino acid residues at the scissile position. The stereochemical integrity of the L-leucine α-center supports stereospecific binding interactions, while the isobutyl side chain contributes to hydrophobic contacts that influence catalytic turnover. The p-nitroanilide chromophore allows comparative readouts when paired with analogs bearing different amino acid side chains or altered electronic environments. The resulting specificity profiles can guide enzyme engineering targets, substrate library design for screening, and selection of amino acid-pNA reagents for routine analytical evaluation in biochemical research.
3. Enzyme Engineering Screening
H-L-Leu-pNA is applied in protein engineering and industrial biocatalysis development as a substrate for rapid screening of protease variants with altered active-site architecture. The compound's leucine-derived side chain and amide-to-pNA leaving group arrangement create a consistent assay substrate that reports changes in substrate binding and catalytic efficiency through chromogenic signal generation. The defined stereochemistry helps distinguish variants that maintain L-residue recognition from those that relax stereochemical constraints. Screening outputs can be translated into downstream selection of improved enzyme candidates for manufacturing-relevant proteolysis processes and for building targeted substrate panels for continued optimization.
4. Analytical Method Development
H-L-Leu-pNA serves as an analytical research intermediate for developing chromogenic assay methods used to monitor protease activity in process-relevant matrices. The pNA moiety provides a direct optical reporter, while the leucine residue identity constrains the substrate to a specific recognition motif that supports method selectivity. The compound can be employed to establish assay calibration strategies and to compare relative activity across conditions where protease composition or inhibitor presence may vary. Method development downstream enables standardized analytical workflows for fine chemical and biochemical process monitoring where amino acid-pNA substrate systems are used to track enzymatic performance.
5. Amino Acid Derivative Synthesis
H-L-Leu-pNA can be utilized as a reference and intermediate in synthetic organic chemistry for constructing related amino acid-pNA conjugates and leucine-based chromogenic substrates. The molecule contains a chiral amino acid core connected to a para-nitroanilide functional group, providing a structural template for designing N-protected or activated amino acid derivatives that preserve stereochemical fidelity. The amide linkage chemistry and the electronic properties of the p-nitroanilide group support downstream derivatization strategies aimed at tuning leaving-group behavior, substrate electronics, and steric presentation of amino acid side chains. Such derivative generation supports combinatorial reagent preparation for substrate panels, assay libraries, and industrial enzyme characterization programs grounded in amino acid chemistry and peptide-like recognition motifs.
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
5. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.